ScoreComparison
Why is 2seventy Bio, Inc. ?
1
With a growth in Net Profit of NAN%, the company declared Very Positive results in Mar 25
- OPERATING CASH FLOW(Y) Highest at USD -54.08 MM
- ROCE(HY) Highest at -1.94%
- PRE-TAX PROFIT(Q) At USD 0.54 has Grown at 104.55%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to 2seventy Bio, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals: Major should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals: Major)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is 2seventy Bio, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
2seventy Bio, Inc.
5.71%
0.06
102.24%
S&P 500
13.22%
0.61
20.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.55%
EBIT Growth (5y)
21.92%
EBIT to Interest (avg)
-203.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.72
Sales to Capital Employed (avg)
0.29
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0.39%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
77
Industry P/E
Price to Book Value
1.21
EV to EBIT
-1.76
EV to EBITDA
-1.98
EV to Capital Employed
1.73
EV to Sales
2.16
PEG Ratio
0.76
Dividend Yield
NA
ROCE (Latest)
-98.35%
ROE (Latest)
1.57%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -54.08 MM
ROCE(HY)
Highest at -1.94%
PRE-TAX PROFIT(Q)
At USD 0.54 MM has Grown at 104.55%
NET PROFIT(Q)
At USD 0.54 MM has Grown at 104.55%
RAW MATERIAL COST(Y)
Fallen by -66.83% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 96.73%
NET SALES(Q)
Highest at USD 22.94 MM
OPERATING PROFIT(Q)
Highest at USD -0.83 MM
OPERATING PROFIT MARGIN(Q)
Highest at -3.6 %
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for 2seventy Bio, Inc.
Net Sales
At USD 22.94 MM has Grown at 142.33%
over average net sales of the previous four periods of USD 9.47 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Operating Cash Flow
Highest at USD -54.08 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD 0.54 MM has Grown at 104.55%
over average net sales of the previous four periods of USD -11.84 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 0.54 MM has Grown at 104.55%
over average net sales of the previous four periods of USD -11.84 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Highest at USD 22.94 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD -0.83 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -3.6 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Debtors Turnover Ratio
Highest at 96.73%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -66.83% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
